Background: A definitive treatment of SARS CoV-2 is yet to arrive and the human death toll
rises exponentially globally. In this health emergency, it might be useful to look into the old …

Introduction: The whole world is on the brink of collapse due to the outbreak of COVID-19
with no solution to treat these cases with any specific drug. Extensive search for the Vaccine …

Objectives COVID-19 patients suffer from the lack of curative therapy. Hence, there is an
urgent need to try repurposed old drugs on COVID-19. Methods Randomized controlled …

Background: The worldwide COVID-19 pandemic was caused by a newly discovered
Coronavirus. The treatment methods for COVID-19 are emerging and rapidly evolving …

Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to
inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. A …

Background and objectives: Various existing non-antiviral drugs are being used to treat
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection based mostly on …

Background: The first case of Infection with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) were diagnosed in Wuhan, China in 2019. In the first half of 2020 this …

Objective We evaluated whether ivermectin combined with doxycycline reduced the clinical
recovery time in adults with COVID-19 infection. Methods This was a randomized, blinded …

Background: Up-to-date, there is no recognized effective treatment or vaccine for the
treatment of COVID-19 that emphasize urgency around distinctive effective therapies. This …

Objective: To evaluate different doses of ivermectin in adult patients with mild COVID-19 and
to evaluate the effect of ivermectin on mortality and clinical consequences. Methods: A …